MétaCan
Menu
Back to cohort
Record W4386139163 · doi:10.17116/kardio202316041362

The effect of Mexidol on the improvement of cognitive status and quality of life parameters in the complex therapy of patients with chronic heart failure II-III functional class

2023· article· en· W4386139163 on OpenAlexaboutno aff
В. В. Толкачева, L. V. Karapetyan, N Khutsishvili, С. А. Галочкин, E.R. Kazakhmedov, Zhanna Kobalava

Bibliographic record

VenueRussian Journal of Cardiology and Cardiovascular Surgery · 2023
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disorders and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsHeart failureQuality of life (healthcare)Class (philosophy)MedicineCognitionIntensive care medicineCardiologyComputer sciencePsychiatryArtificial intelligenceNursing

Abstract

fetched live from OpenAlex

Objective. Evaluation of the effect of mexidol as part of the complex therapy of heart failure for 10 weeks on cognitive status, quality of life parameters, asthenic syndrome and anxiety level in patients with CHF of functional class II-III (according to NYHA classification) Methods. The open randomized study included 60 comorbid patients with ischemic heart disease (CHD) and stable chronic heart failure (CHF) with cognitive impairment (CI) ≤24 points on the Montreal Cognitive Function Assessment Scale (MoCA). The average age of patients was 73.4±8.6 years, 53% were male, the average ejection fraction was 43.5±10.6%. 30 patients were included in the group of standard CHF therapy with additional administration of mexidol (500 mg intravenously once a day for 14 days, then 250 mg 3 times a day for 8 weeks) and 30 patients in the standard therapy group. Initially and at the end of the study, the effect of therapy on the cognitive status of patients was assessed according to the Montreal Cognitive Function Assessment Scale (MoCA), the level of anxiety on the Beck scale, the severity and dynamics of asthenic syndrome on the subjective asthenia assessment scale (MFI-20), the health profile according to the EQ-5D-5L questionnaire and the quality of life parameters according to the results of the assessment of the Minnesota (MLHFQ), Kansas (Kansas City Cardiomyopathy Questionnaire, KCCQ) and the SF36 questionnaire «Quality of life Assessment». Results. Patients who received mexidol in addition to standard therapy showed a significant improvement in cognitive function by 21%, a decrease in anxiety by 38% and the severity of asthenic syndrome by 12%, an improvement in general well-being by 25% according to the EQ-5D-5L questionnaire, as well as the quality of life according to the Minnesota questionnaire by 48%, according to the Kansas questionnaire — by 39%. Conclusion. Mexidol, when added to the standard therapy of patients with CHF of functional class II-III, significantly improves cognitive status, quality of life parameters, reduces the severity of asthenic syndrome and anxiety levels.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.276

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.037
GPT teacher head0.248
Teacher spread0.210 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueRussian Journal of Cardiology and Cardiovascular SurgerySame topicNeurological Disorders and TreatmentsFrench-language works237,207